These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32231716)

  • 1. Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer.
    Qian L; Su H; Wang G; Li B; Shen G; Gao Q
    J Cancer; 2020; 11(11):3114-3123. PubMed ID: 32231716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4.
    Chen F; Zhu L; Hu J; Jiang S; Liu H; Zheng J; Wang J; Wang F; Li Z
    Oncol Lett; 2020 Nov; 20(5):171. PubMed ID: 32934738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
    Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells].
    Kang X; Lu P; Cui Y; Wang Y; Zhang Q; Gong Y; Xu Z
    Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):490-6. PubMed ID: 26463323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bufalin suppresses the proliferation and metastasis of renal cell carcinoma by inhibiting the PI3K/Akt/mTOR signaling pathway.
    Xie J; Lin W; Huang L; Xu N; Xu A; Chen B; Watanabe M; Liu C; Huang P
    Oncol Lett; 2018 Sep; 16(3):3867-3873. PubMed ID: 30128000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
    Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway.
    Bi T; Zhu A; Yang X; Qiao H; Tang J; Liu Y; Lv R
    Cytotechnology; 2018 Feb; 70(1):439-448. PubMed ID: 29110119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ; Fu JY; Zhao ZM; Chen CQ
    Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis In Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.
    Wu SH; Hsiao YT; Kuo CL; Yu FS; Hsu SC; Wu PP; Chen JC; Hsia TC; Liu HC; Hsu WH; Chung JG
    Am J Chin Med; 2015; 43(6):1247-64. PubMed ID: 26446205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT.
    Ye J; Qi L; Liang J; Zong K; Liu W; Li R; Feng R; Zhai W
    J Cancer; 2021; 12(12):3548-3557. PubMed ID: 33995632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway.
    Liu Y; Bi T; Shen G; Li Z; Wu G; Wang Z; Qian L; Gao Q
    Cytotechnology; 2016 Jan; 68(1):123-133. PubMed ID: 25037728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression.
    Wang J; Cai H; Xia Y; Wang S; Xing L; Chen C; Zhang Y; Xu J; Yin P; Jiang Y; Zhao R; Zuo Q; Chen T
    Oncotarget; 2018 May; 9(34):23320-23333. PubMed ID: 29805736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin inhibits migration and invasion in human hepatocellular carcinoma SK-Hep1 cells through the inhibitions of NF-kB and matrix metalloproteinase-2/-9-signaling pathways.
    Chen YY; Lu HF; Hsu SC; Kuo CL; Chang SJ; Lin JJ; Wu PP; Liu JY; Lee CH; Chung JG; Chang JB
    Environ Toxicol; 2015 Jan; 30(1):74-82. PubMed ID: 23949904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and identification of tumor-initiating cell properties in human gallbladder cancer cell lines using the marker cluster of differentiation 133.
    Yu J; Tang Z; Gong W; Zhang M; Quan Z
    Oncol Lett; 2017 Dec; 14(6):7111-7120. PubMed ID: 29344142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway.
    Qian L; Li X; Ye P; Wang G; Dai W; Liu Y; Gao Q; Shen G
    Cytotechnology; 2018 Feb; 70(1):83-94. PubMed ID: 29170841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.
    Peng X; Liu Y; Zhu S; Peng X; Li H; Jiao W; Lin P; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2921-2936. PubMed ID: 31620898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation.
    Li C; Wang C; Xing Y; Zhen J; Ai Z
    Oncotarget; 2016 Apr; 7(14):17751-9. PubMed ID: 26910892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways.
    Chueh FS; Chen YY; Huang AC; Ho HC; Liao CL; Yang JS; Kuo CL; Chung JG
    Environ Toxicol; 2014 Jan; 29(1):21-9. PubMed ID: 21922632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.